Tag:
layoffs
Latest Headlines
Latest Headlines
Sanofi, France remain at odds over fate of 600 R&D jobs
Sanofi CEO Chris Viehbacher has reviled the company's research site in Toulouse, France as unproductive and overly costly. But try as he may, he can't seem to rid himself and the company of the center and its 612 researchers, a move Viehbacher initially advocated as part of 2,500 job reduction plan in the mother country.
Sanofi balks on jobs promises at R&D site in Toulouse
Sanofi can't shake the underproductive R&D site in Toulouse, France, without a fight from workers and French government officials. In the latest chapter of the ongoing feud, the Paris-based drug giant and a familiar critic in France's government show how far apart they stand on the fate of the research operation that brought the world the blood-thinner
UPDATED: Biotech trio to take over Alderley labs as AstraZeneca heads south
It's the start of what locals hope will be a continued migration of smaller companies to the Alderley campus to fill the void of AZ's massive exit from the area.
UPDATED: Lilly tells 1,624 their sales jobs are gone or changed
Salesforce cuts are coming down at Eli Lilly, and 40% of its U.S. sales force will be out. According to the company, the drugmaker sent a state Warn Notice to 1,624 sales positions, of which about 1,000 will be let go.
Novartis changes CFOs, reveals cuts to workforce and chairman pay
While the U.S. government was announcing its kickbacks lawsuit against Novartis, the Swiss drugmaker was putting the finishing touches on a few press releases of its own.
Roche to shed 170 jobs in diagnostics restructuring
Roche plans to cut 170 jobs in the U.S. and Germany.
AbbVie to hack hundreds of reps from cardiovascular sales ranks
AbbVie has a new distinction. It may be the youngest pharma company ever to lay off hundreds of salespeople. Bloomberg reports that the drugmaker, spun off by Abbott Laboratories as of January 1, plans to jettison its cardiovascular salesforce, with layoffs in the "mid-hundreds."
Sanofi downsizing in France drags on
Sanofi CEO Chris Viehbacher has been openly critical of his research operation in Toulouse, France. He said the researchers are costing too much money and haven't developed an important drug in 20 years.
Eli Lilly to lay off hundreds in sales as Cymbalta nears edge of patent cliff
Here is a business reality that hundreds of Eli Lilly sales employees are going to have to align themselves with quite soon: They are about to lose their jobs.
Covidien plans to slash 183 jobs in NY plant closure
Covidien is planning to shut down its Argyle, NY, plant in 2014, doing away with 183 jobs in its catheter business.
